Atopic Dermatitis in Asians: A Review on Genetics, Clinical Presentation, and Therapeutic Implications
DOI:
https://doi.org/10.58931/cdt.2025.63145Abstract
Atopic dermatitis (AD) is a common, multifactorial, and pruritic inflammatory skin condition with a chronic relapsing course. It typically manifests in infancy or early childhood and is often associated with other atopic conditions, such as asthma and allergic rhinoconjunctivitis. As the most prevalent chronic inflammatory skin disease worldwide, AD affects individuals across a wide range of racial and ethnic backgrounds. Recent studies suggest that Central Asia has the highest pediatric prevalence of AD in 2021, with a rate of 10.5%, surpassing the 5.4% prevalence observed in high‑income North America. According to the 2021 Census, individuals of Asian descent constitute the third-largest population group in Canada, following those of European and North American descent, with nearly half originating from East or Southeast Asia. Furthermore, Asians represent Canada’s fastest-growing demographic. This review highlights the genetic factors, clinical presentations, and therapeutic considerations for AD in Asian populations, aiming to improve understanding and inform tailored treatment approaches.
References
Jin L, Ge J, Cheng Y, Deng D, Wan P. Worldwide prevalence of atopic dermatitis in children between 2000 and 2021: a systematic analysis. Ann Allergy Asthma Immunol. 2025;134(5):603-609.e6. doi:10.1016/j.anai.2024.12.005
Yew YW, Loh M, Brown SJ. Understanding atopic dermatitis in asian and european population cohorts using complementary omics techniques. J Invest Dermatol. 2025;145(6):1283-1293. doi:10.1016/j.jid.2024.08.036
Dahabreh D, Lo JC, Chandra M, Chiou AS, McCleskey PE, Darbinian JA, et al. Atopic dermatitis prevalence among Asian American and Pacific Islander children: a retrospective study in a Northern California health care system. J Am Acad Dermatol. 2025;92(6):1413-1416. doi:10.1016/j.jaad.2025.02.016
Kim M, Yoo J, Kim J, Park J, Han E, Jang W, et al. Association of FLG single nucleotide variations with clinical phenotypes of atopic dermatitis. PLoS One. 2017;12(12):e0190077. doi:10.1371/journal.pone.0190077
Zhang H, Guo Y, Wang W, Shi M, Chen X, Yao Z. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis. Allergy. 2011;66(3):420–427. doi:10.1111/j.1398-9995.2010.02493.x
Park J, Jekarl DW, Kim Y, Kim J, Kim M, Park YM. Novel FLG null mutations in Korean patients with atopic dermatitis and comparison of the mutational spectra in Asian populations. J Dermatol. 2015;42(9):867–873. doi:10.1111/1346-8138.12935
Ching GK, Hon KL, Ng PC, Leung TF. Filaggrin null mutations in childhood atopic dermatitis among the Chinese. Int J Immunogenet. 2009;36(4):251–254. doi:10.1111/j.1744-313X.2009.00859.x
On HR, Lee SE, Kim SE, Hong WJ, Kim HJ, Nomura T, et al. Filaggrin mutation in Korean patients with atopic dermatitis. Yonsei Med J. 2017;58(2):395–400. doi:10.3349/ymj.2017.58.2.395
Park KY, Li K, Seok J, Seo SJ. An analysis of the filaggrin gene polymorphism in Korean atopic dermatitis patients. J Korean Med Sci. 2016;31(7):1136–1142. doi:10.3346/jkms.2016.31.7.1136
Ma L, Zhang L, Di ZH, Zhao LP, Lu YN, Xu J, et al. Association analysis of filaggrin gene mutations and atopic dermatitis in Northern China. Br J Dermatol. 2010;162(1):225–227. doi:10.1111/j.1365-2133.2009.09539.x
Handa S, Khullar G, Pal A, Kamboj P, De D. Filaggrin gene mutations in hand eczema patients in the Indian subcontinent: a prospective case-control study. Contact Dermatitis. 2019;80(6):359–364. doi:10.1111/cod.13233
Chauhan A, Panigrahi I, Singh M, Attri SV, Agarwal A, Singh M. Prevalence of filaggrin gene R501X mutation in Indian children with allergic diseases. Indian J Pediatr. 2020;87(8):587–590. doi:10.1007/s12098-020-03231-0
Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340–357. doi:10.1111/exd.13514
Chan TC, Sanyal RD, Pavel AB, Glickman J, Zheng X, Xu H, et al. Atopic dermatitis in Chinese patients shows T(H)2/T(H)17 skewing with psoriasiform features. J Allergy Clin Immunol. 2018;142(3):1013–1017. doi:10.1016/j.jaci.2018.06.016
Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(5):449–455. doi:10.1016/j.anai.2018.11.015
Noda S, Suarez-Farinas M, Ungar B, Kim SJ, de Guzman Strong C, Xu H, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015;136(5):1254–1264. doi:10.1016/j.jaci.2015.08.015
Venkatesan J, Janumpally R, Gimkala A, Megavaran V, Myklebust H, Ramana Rao GV. Importance of “Telephone Cardiopulmonary Resuscitation” in out-of-hospital cardiac arrest in India. Indian J Community Med. 2020;45(2):194–198. doi:10.4103/ijcm.IJCM_223_19
Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, et al. Atopic dermatitis in African American patients is T(H)2/T(H)22-skewed with T(H)1/T(H)17 attenuation. Ann Allergy Asthma Immunol. 2019;122(1):99–110 e116. doi:10.1016/j.anai.2018.08.024
Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, et al. The impact of skin hyperpigmentation and hyperchromia on quality of life: a cross-sectional study. J Am Acad Dermatol. 2017;77(4):775–778. doi:10.1016/j.jaad.2017.05.009
Zhou J, Chen H, Zhou S, Liu A, Liang S, Sun X, et al. Trends in atopic dermatitis prevalence among the Chinese population (1990-2021) with projections for 2022-2030. Pediatr Allergy Immunol. 2024;35(10):e14271. doi:10.1111/pai.14271
Price KN, Krase JM, Loh TY, Hsiao JL, Shi VY. Racial and ethnic disparities in global atopic dermatitis clinical trials. Br J Dermatol. 2020;183(2):378–380. doi:10.1111/bjd.18938
Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019;143(1):1–11. doi:10.1016/j.jaci.2018.10.032
